Primary Site >> Colorectal Cancer
Gene >> CES1
| 1. | |||||||||||
| Journal: | Digestion. 1992;51(1):10-7. | ||||||||||
| Title: | Regulation of cholesterol metabolism and low-density lipoprotein binding in human intestinal Caco-2 cells. | ||||||||||
| Author: | Reimann, F M|Herold, G|Grosshans, I|Rogler, G|Fellermann, K|Stange, E F | ||||||||||
| PMID: | 1639221 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2002 Apr;49(4):329-35. | ||||||||||
| Title: | Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell lines. | ||||||||||
| Author: | Pavillard, Valerie|Agostini, Cecile|Richard, Sophie|Charasson, Virginie|Montaudon, Daniele|Robert, Jacques | ||||||||||
| PMID: | 11914913 | ||||||||||
| 3. | |||||||||||
| Journal: | Clin Cancer Res. 2002 Aug;8(8):2605-11. | ||||||||||
| Title: | Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. | ||||||||||
| Author: | Xu, Guang|Zhang, Wanghai|Ma, Margaret K|McLeod, Howard L | ||||||||||
| PMID: | 12171891 | ||||||||||
| 4. | |||||||||||
| Journal: | Clin Cancer Res. 2003 Oct 15;9(13):4983-91. | ||||||||||
| Title: | Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. | ||||||||||
| Author: | Sanghani, Sonal P|Quinney, Sara K|Fredenburg, Tyler B|Sun, Zejin|Davis, Wilhelmina I|Murry, Daryl J|Cummings, Oscar W|Seitz, David E|Bosron, William F | ||||||||||
| PMID: | 14581373 | ||||||||||
| 5. | |||||||||||
| Journal: | J Pharmacol Exp Ther. 2005 Jun;313(3):1011-6. | ||||||||||
| Title: | Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide. | ||||||||||
| Author: | Quinney, S K|Sanghani, S P|Davis, W I|Hurley, T D|Sun, Z|Murry, D J|Bosron, W F | ||||||||||
| PMID: | 15687373 | ||||||||||
| 6. | |||||||||||
| Journal: | Eur J Cancer. 2008 Jan;44(2):310-7. | ||||||||||
| Title: | Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity. | ||||||||||
| Author: | Guichard, Sylvie M|Macpherson, Janet S|Mayer, Iain|Reid, Eilidh|Muir, Morwenna|Dodds, Michael|Alexander, Susan|Jodrell, Duncan I | ||||||||||
| PMID: | 18077151 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2012 Jul;70(1):25-32. | ||||||||||
| Title: | Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53. | ||||||||||
| Author: | Chiorean, E Gabriela|Sanghani, Sonal|Schiel, Marissa A|Yu, Menggang|Burns, Matthew|Tong, Yan|Hinkle, David T|Coleman, Nicki|Robb, Bruce|LeBlanc, Julia|Clark, Romnee|Bufill, Jose|Curie, Colleen|Loehrer, Patrick J|Cardenes, Higinia | ||||||||||
| PMID: | 22610353 | ||||||||||
| 8. | |||||||||||
| Journal: | J Pharmacol Exp Ther. 2014 Oct;351(1):61-6. | ||||||||||
| Title: | Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-Ibuprofen. | ||||||||||
| Author: | Mattheolabakis, George|Wong, Chi C|Sun, Yu|Amella, Carol A|Richards, Robert|Constantinides, Panayiotis P|Rigas, Basil | ||||||||||
| PMID: | 25047517 | ||||||||||
| 9. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2015 Feb 13;457(3):363-9. | ||||||||||
| Title: | 3D-fibroblast tissues constructed by a cell-coat technology enhance tight-junction formation of human colon epithelial cells. | ||||||||||
| Author: | Matsusaki, Michiya|Hikimoto, Daichi|Nishiguchi, Akihiro|Kadowaki, Koji|Ohura, Kayoko|Imai, Teruko|Akashi, Mitsuru | ||||||||||
| PMID: | 25576862 | ||||||||||
| 10. | |||||||||||
| Journal: | ANZ J Surg. 2017 Oct;87(10):E112-E115. | ||||||||||
| Title: | Colorectal multidisciplinary meetings: how do they affect the timeliness of treatment? | ||||||||||
| Author: | Nikolovski, Zoran|Watters, David A K|Stupart, Douglas|Guest, Glenn D | ||||||||||
| PMID: | 25913227 | ||||||||||
| 11. | |||||||||||
| Journal: | Chembiochem. 2017 Jul 4;18(13):1204-1215. | ||||||||||
| Title: | Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid. | ||||||||||
| Author: | Mathew, Mohit P|Tan, Elaine|Labonte, Jason W|Shah, Shivam|Saeui, Christopher T|Liu, Lingshu|Bhattacharya, Rahul|Bovonratwet, Patawut|Gray, Jeffrey J|Yarema, Kevin J | ||||||||||
| PMID: | 28218815 | ||||||||||
| 12. | |||||||||||
| Journal: | Pharmacol Res. 2017 Jun;120:133-137. | ||||||||||
| Title: | Identification of new SNPs associated with severe toxicity to capecitabine. | ||||||||||
| Author: | Pellicer, Marta|Garcia-Gonzalez, Xandra|Garcia, Maria I|Robles, Luis|Gravalos, Cristina|Garcia-Alfonso, Pilar|Pachon, Vanessa|Longo, Federico|Martinez, Virginia|Blanco, Carolina|Iglesias, Irene|Sanjurjo, Maria|Lopez-Fernandez, Luis A | ||||||||||
| PMID: | 28347776 | ||||||||||
| 13. | |||||||||||
| Journal: | Biol Pharm Bull. 2018;41(5):697-706. | ||||||||||
| Title: | Development of a Caco-2 Cell Line Carrying the Human Intestine-Type CES Expression Profile as a Promising Tool for Ester-Containing Drug Permeability Studies. | ||||||||||
| Author: | Ishizaki, Yuma|Furihata, Tomomi|Oyama, Yusuke|Ohura, Kayoko|Imai, Teruko|Hosokawa, Masakiyo|Akita, Hidetaka|Chiba, Kan | ||||||||||
| PMID: | 29709907 | ||||||||||